Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

December date set for advisory committee review of Bexxar

Nov. 8, 2002

Erbitux clinical development program update

Nov. 8, 2002

Guilford submits amendment to Gliadel Wafer sNDA

Nov. 8, 2002

Series of antiangiogenic and vascular-damaging agents under study at AstraZeneca

Nov. 8, 2002

Marine-derived cytotoxic agents a highlight of the ESMO 2002 congress

Nov. 8, 2002

Chemotherapy-induced neuropathy reported to improve with levocarnitine acetyl hydrochloride

Nov. 8, 2002

New data on the tolerability of gimatecan discussed at ESMO 2002

Nov. 8, 2002

Lexrite receives phase I SBIR grant from NCI

Nov. 7, 2002

Peregrine meets with FDA to discuss phase III Cotara trial design

Nov. 6, 2002

New ER-modulatory isoflavonoids for cancer and other conditions

Nov. 6, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...